Dysfunctional (anovulatory) uterine bleeding

Indication for Medroxyprogesterone

Population group: Suitable for both men and women, only adults (18 - 65 years old)

For this indication, competent medicine agencies globally authorize below treatments:

2.5-10 mg once daily

Route of admnistration


Defined daily dose

2.5 - 10 mg

Dosage regimen

From 2.5 To 10 mg once every day

Detailed description

2.5-10 mg daily for 5-10 days commencing on the assumed or calculated 16th – 21st day of the cycle. Treatment should be given for two consecutive cycles. When bleeding occurs from a poorly developed proliferative endometrium, conventional oestrogen therapy may be employed in conjunction with medroxyprogesterone acetate in doses of 5-10 mg for 10 days.

Active ingredient

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

Read more about Medroxyprogesterone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner